Richard Vines: An update on the work of Rare Cancers Australia in Asia
Richard Vines, Chair – Rare Cancers Australia, made the following post on LinkedIn: .
“An update on the work of Rare Cancers Australia in Asia.”
Quoting Herbert Loong reshared the post and added the following:
“Thanks Richard Vines and Rare Cancers Australia for organising this workshop. I believe there is a lot of synergism that can be cultivated in patients advocacy in the AsiaPacific region. Happy to take part and support these endeavours.”
Read further.
Source: Richard Vines/LinkedIn and Herbert Loong/LinkedIn
Dr. Herbert H. F. Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.
Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023